The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
J | Antiinfectives for systemic use | |
2
|
J01 | Antibacterials for systemic use | |
3
|
J01F | Macrolides, lincosamides and streptogramins | |
4
|
J01FF | Lincosamides | |
5
|
J01FF01 | Clindamycin |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Code | Route | Amount | Notes |
|---|---|---|---|
| ORAL | Oral | 1.2 g | |
| PAREN | Parenteral | 1.8 g |
| Active Ingredient |
|---|
|
Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis. |
| Document | Type | Information Source | |
|---|---|---|---|
| CLINDAHEXAL Capsule | MPI, Generic | Health Products Regulatory Authority (ZA) | |
| DALACIN C Capsule | MPI, EU: SmPC | Medicines and Medical Devices Safety Authority (NZ) | |
| DALACIN CREAM Vaginal Cream | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.